Sri Lanka heralds nanotechnology

Sri Lanka will be a destination for nanotechnology research and development, said Chairman (SLINTEC) Dr. Mahesh Amalean, at a ceremony to launch the partnership between SLINTEC and Nagarjuna Fertilisers and Chemicals Ltd,(NFCL), India to develop the next generation nanotechnology-based plant nutrition solutions.

Full Story

The number of tourists arrivals during the first two months of this year recorded a 21 percent growth with 169,423 visitors compared to 139,994 recorded in the corresponding months last year. Latin America and the Caribbean market dominated arrivals with a 83.8 percent growth notching 430 visitors compared to 234 recorded in the corresponding period last year.

Full Story

Standard Chartered Bank introduced SME banking to Sri Lanka last week. It offers facilities and tailor made solutions that are commonly accessible by large corporate and (MNCs), to the Sri Lankan SME sector covering four the areas of ; working capital management, business protection, yield enhancement and business expansion.

Full Story

A single visa system is important, to achieve the objectives of the South Asian Subregion Tourism Forum (SASTF) said the director of Shangri la Tours and the President of Nepal Tours Association, Ashok Polkharel told SASTF in Colombo last week.

Full Story

Sri Lanka Telecom (SLT), launched a Technology Experience Centre a platform where enterprise and SME customers can experience first-hand, the companys enhanced services provided through state-of-the-art technology. The one-of-a-kind SLT Technology Experience Centre is at the Companys head office premises at Fort, Colombo.

Full Story

See more here:
Sri Lanka heralds nanotechnology

Seeing the future

WORCESTER The group of University of Massachusetts Medical School students who gathered late yesterday was as varied as the paths before them. The students will not graduate until June, but yesterday was Match Day, the day they learn where they will do their residency.

Students at medical schools across the country opened their envelopes at the same time. At UMass, the group of 116 students included a couple who will marry today, a veteran who plans to return to combat zones as a doctor and a man who left his home in Sudan at age 11 as one of the Lost Boys.

Timothy J. Menz, who is originally from Braintree, and Tania Visnaskas, originally from Chelmsford, are making a weekend of matches. The two met in fall 2007, their first year of medical school, became friends and dated.

He proposed on Valentines Day in 2011 and yesterday she jumped into his arms as they learned they were both bound for Brown University-affiliated hospitals, he to Rhode Island Hospital in Providence for pediatrics and she to Memorial Hospital in Pawtucket for family medicine.

Today, the couple will get married in Haverhill.

It was like two months after we started dating that I said I would marry him tomorrow, Ms. Visnaskas said. Tomorrow took about three years.

Theyre planning a New Hampshire getaway after the wedding, followed by a trip to Disneyworld in a couple of months, because we didnt think it was legal for a pediatrician not to have gone to Disney World, Mr. Menz joked.

Elsewhere in the crowded lobby yesterday, Micah B. Blais of Holden was celebrating his acceptance into a residency at Harvard University-affiliated hospitals to start his career in orthopedic surgery. Mr. Blais, 32, studied information systems while at West Point, but after two tours of duty with the Army in Iraq, which he concluded as a captain, he decided to pursue medicine.

While deployed, he saw the relationship the doctors were able to maintain with the soldiers and the Iraqi civilians, he said. In between the tours he started in 2004 and 2007, he took a couple of night courses to qualify for medical school. The military is paying for his medical training, and he plans to work in combat zones.

In the meantime, however, he and his wife, Kim Anderson, are looking forward to the birth of their first child and will move closer to Boston.

Read this article:
Seeing the future

Envelope, please: UT Houston med students, future docs across U.S. learn their fate on Match Day

With four years of medical school nearly behind them, more than 200 excited students at The University of Texas Health Science Center at Houston Medical School found out on Match Day Friday where they will begin the next phase of their medical training.

Match Day is an annual event that occurs simultaneously across the country as students are matched with residencies with the aid of computer technology and the National Resident Matching Program. At UTHealth, students, friends and loved ones gathered Friday morning in Webber Plaza.

This is the moment weve all been waiting for, said Katherine Lusk, president of UTHealth Medical Schools Class of 2012.

The tight-knit class forged friendships during Hurricane Ike, which struck the Gulf Coast right before the students first big exam. Since then, together they have learned what it takes to be physicians dedicated to excellence in patient care.

In the months leading up to Match Day, the students interviewed with residency programs across the country. Anesthesiology, family medicine, internal medicine, pediatrics and general surgery are among some of the most popular areas of medicine that members of UTHealth Medical Schools Class of 2012 have selected for residency training. Many of them would like to stay in Texas for that training.

Our students are truly second to none and always do very well in the match, said Giuseppe N. Colasurdo, M.D., president ad interim of UTHealth and dean of the UTHealth Medical School.

Surrounded by family, friends and faculty, the students open envelopes to reveal the location of their residency. Will it be Houston? Will it be someplace else?

Here are stories from a few of the students who participated in this years match:

Lisa Osterhout, 29, had promising careers as a marketing executive and graphic artist, but she discovered that the volunteer work she was doing on weekends was far more rewarding that her weekdays promoting popular rock bands and creating 3D special effects. She was already contemplating a career move when, in 2004, she suddenly became sick. Two surgeries, encouragement from family and friends and news reports about the Indian Ocean tsunami ultimately led to her decision to become a physician committed to public service. In the summer of 2005, the Pearland native returned to The University of Texas at Austin, where she had previously earned a degree in marketing, to complete her pre-med coursework. Medicine allows me to integrate the creative aspects from my previous work while focusing on service, she said. Since enrolling at the UTHealth Medical School, she has served as executive director at the H.O.M.E.S. Clinic in Houston and founded a sustainable project to improve health in childrens homes in Kenya. She plans to do her graduate medical training in pediatrics.

When Irving Basanez arrived on the UTHealth campus in 2008 at the age of 19, he was the youngest student ever admitted to the Medical School. Basanez - who moved with his family from Veracruz, Mexico when he was 8 years old to live in Pharr, Texas - finished high school in three years and pushed himself to finish college in the same length of time. During his first year of medical school, he became interested in otolaryngology and decided he wanted to do his residency training in the ear, nose and throat (ENT) specialty. He also became interested in global health issues and participated in a number of mission trips, including one to Nigeria where he donated his own blood to save a woman from bleeding to death. Like his fellow classmates who are participating in Match Day, he doesnt yet know the location of his residency, but he does know where he would ultimately like to establish his medical practice. Ive had such great mentors here. I want to pay it forward and encourage and mentor students with an interest in ENT and global health, Basanez said. And I would like to come back and practice in the (Rio Grande) Valley. Now 22, Basanez jokes, Medical school has aged me.

Continue reading here:
Envelope, please: UT Houston med students, future docs across U.S. learn their fate on Match Day

With ALS, mentor to USF medical residents is now a patient

By Patty Ryan, Times Staff Writer Patty RyanTampa Bay Times In Print: Saturday, March 17, 2012

TAMPA Ten years ago, when Dr. Michael Flannery became director of the internal medicine residency program at the University of South Florida's medical school, he made a commitment. Each day, he would say a rosary.

Last summer, he added a new prayer: If there's anything I need to do or to know, tell me.

He had been having premonitions of his own death. His body was beginning to validate them.

Flannery had seen the muscle weakness and spasms in patients. He knew what the symptoms might mean. As he searched for a more hopeful diagnosis, he kept his fears to himself. Then, one day in August, he and his wife learned the worst:

Flannery, 51, who has devoted his life to healing and the making of healers, has a terminal disease for which there is no cure ALS, or Lou Gehrig's disease.

He has three children, including a boy just 11. He knows he can't change the course of the disease, which could paralyze him and keep him from breathing on his own. He can only influence the memories that his family will make together until then.

And so, after the diagnosis but before others knew, he told his wife, "Let's go out and celebrate."

This is Michael Flannery. He goes to Biloxi to volunteer after Hurricane Katrina. He opens a free clinic in Pasco County. He gives educational scholarships, six a year ranging from $500 to $1,000, to future doctors, nurses and pharmacists. One is earmarked for hospital janitors who want to go back to school.

Over 21 years, he has trained hundreds of new doctors.

Read the original post:
With ALS, mentor to USF medical residents is now a patient

Marshall University medical school reaches 100 percent milestone

Every single graduating medical student from Marshall University's Joan C. Edwards School of Medicine has been placed in a residency program. University officials said Friday that's the first time ever 100 percent of the class has matched.

The National Residency Matching Program (NRMP) pairs graduating seniors with graduate medical programs across the country where they will train for the next three to five years.

"For the first time in the history of the School of Medicine, 100 percent of our students have matched in their chosen medical specialties, exceeding the average of 95 percent that we've had for the last five years," said Dr. Marie Veitia, associate dean, student affairs.

In all, 64 seniors learned their residency placements at noon Friday when they and their counterparts nationwide opened envelopes containing their residency decisions.

A little more than 67 percent of graduating seniors will enter fields defined as primary care in West Virginia - family medicine, internal medicine, obstetrics/gynecology, internal medicine/pediatrics, and pediatrics - continuing Marshall's mission of educating physicians for the nation's rural areas. Additionally, about one-third of the class will remain in West Virginia, according to a news release from Marshall University. Of those, 17 will train at Marshall.

"We are delighted that a significant number elected to remain at Marshall while others matched in primary care and highly competitive fields of medicine such as emergency medicine, radiology, and anesthesiology at schools across the country," Veitia said. "Marshall students matched at programs at Duke, University of Virginia, Virginia Commonwealth, Emory and three outstanding programs in California."

View post:
Marshall University medical school reaches 100 percent milestone

Eating healthy key for latest centenarian

by BY DANIELLE STANTON stanton@monroenews.com , last modified March 16. 2012 12:07PM

Evening News photo by BRYAN BOSCH Josephine Hetu is turning 100 today.

Spread The News

Josephine Hetu is celebrating her 100-year birthday today.

The secret to her longevity: tomatoes.

Her niece, Patty Hochradel, said Ms. Hetu would often demand tomatoes. She also eats blueberries and walnuts. Not only would she eat healthy and exercise, she would educate herself on fitness.

I read all the health articles I came across, Ms. Hetu said in a recent interview. I like tomatoes and I like salads. I tried to eat right. Thats whats kept me healthy.

Her secret to keeping her skin young and healthy looking: Wash with hot water, rinse with cold and no soap.

The Elderly Solutions resident is not surprised she has lived so long because she kept such good care of herself. Not only would she eat right, but she would do leg and stomach exercises in bed every morning.

Shes very proud of the fact that she has all her own teeth and has no cavities.

Continue reading here:
Eating healthy key for latest centenarian

'Invincible' Tendulkar's incredible milestone may never be matched: Report

London, Mar 17(ANI): Sachin Tendulkar achieved immortality after he finally scored his long awaited 100th century against Bangladesh in an Asia Cup match in the Shere Bangla National Stadium, Dhaka on Friday.

Many have already touted Tendulkar's magical feat as unmatchable, a record, which might stay forever.

His 100th century is 29 more centuries than his nearest challenger on the all-time list, Australia's Ricky Ponting.

According to the Wall Street Journal, it has been a long wait of a year and four days, but Sachin Tendulkar, the Little Master, has finally done it. He has scored 100 centuries in international cricket, which is an incredible sporting feat that may never be matched.

Tendulkar won't care a bit about the venue or opposition since any international century is special, and he's just scored 100 of them. This latest one is perhaps the sweetest, as it came when Tendulkar was facing an unfamiliar and unfair amount of criticism, it said.

It's difficult to play down this sporting achievement as scoring a century of centuries was deemed unthinkable even before Tendulkar came along, making his debut in 1989 as a mere 16-year-old, the youngest cricketer ever to represent India, it added.

The report said no other batsman in history has come close to achieving what Tendulkar has as he is the top scorer in Test cricket by a country mile, with over 15,000 runs to his name.

Tendulkar is also the top scorer in One-Day Internationals with more than 18,000 runs, streets ahead of Ponting, who is second on the list with 13,704, it added. (ANI)

See original here:
'Invincible' Tendulkar's incredible milestone may never be matched: Report

2012 – The Profit of Your Death – Video

18-02-2012 15:05 There is a cure for cancer, but you, your mother, your child or husband are not allowed to have it, because someone needs to make money off of you and your loved ones death - okay? Under the capitalist sun, there is nothing sacred. Money talks. - Li Chuan Chen, PhD from "Cancer is a Serious Business" Burzynski - Cancer Is Serious Business - BurzynskiMovie.com http://www.youtube.com ... er&list=UL Burzynski, the Movie is the story of a medical doctor and Ph.D biochemist named Dr. Stanislaw Burzynski who won the largest, and possibly the most convoluted and intriguing legal battle against the Food & Drug Administration in American history. His victorious battles with the United States government were centered around Dr. Burzynski's gene-targeted cancer medicines he discovered in the 1970's called Antineoplastons, which have currently completed Phase II FDA-supervised clinical trials in 2009 and could begin the final phase of FDA testing in 2011--barring the ability to raise the required $300 million to fund the final phase of FDA clinical trials. When Antineoplastons are approved, it will mark the first time in history a single scientist, not a pharmaceutical company, will hold the exclusive patent and distribution rights on a paradigm-shifting medical breakthrough. Antineoplastons are responsible for curing some of the most incurable forms of terminal cancer. Various cancer survivors are presented in the film who chose these medicines instead of surgery, chemotherapy or radiation ...

View post:
2012 - The Profit of Your Death - Video

Soon, gene technology to produce novel plastics and textiles from waste

Washington, March 17 (ANI): New biotechnological and chemical methods will facilitate efficient production of chemicals, materials and fuels from renewable natural resources, such as agricultural or industrial waste materials, say researchers.

The Academy of Finland Centre of Excellence (CoE) in White Biotechnology - Green Chemistry Research is focusing on the research and development of microbial cells, or cell factories, for producing new useful compounds from sugars in plant biomass.

These compounds can be used, for example, for manufacturing bioplastics or in medical applications.

"By means of gene technology, we can modify microbial metabolism and thereby produce organic acids for a wide range of industrial applications. They can be used, among other things, for manufacturing new plastic and textile materials, or packaging technologies," explained Merja Penttila, Research Professor and Director of the Centre of Excellence from VTT Technical Research Centre of Finland.

New methods play a key role when various industries are developing environmentally friendly and energy-efficient production processes.

Use of renewable natural resources, such as agricultural or industrial waste materials, to replace oil-based raw materials will make industries less dependent of fossil raw materials and, consequently, reduce carbon dioxide emissions into the atmosphere.

The CoE also develops highly sensitive measuring methods and investigates microbial cell functions at molecular level.

"We need this information to be able to develop efficient bioprocesses for the future. For instance, we build up new micro- and nanoscale instruments for measuring and controlling microbial productivity in bioreactors during production," said Penttila.

The metabolism of microbes is modified so that they will convert plant biomass sugars into sugar acids and their derivatives.

These compounds can potentially serve as raw materials for new types of polyesters, whose properties - such as water solubility and extremely rapid degradation into natural substances - can be used, for example, in medicine.

See the original post:
Soon, gene technology to produce novel plastics and textiles from waste

Steve Heilig: Better Living Through Chemistry: A Reluctant Scientific and Environmental Hero Moves On

When I was a kid in Southern California, I had a pal up the street whose dad taught chemistry at the local university. That's all I really knew about the man, other than that he was very tall (6'5"!). He was always welcoming at their home when we did stop in after skateboarding, but by the time we were adolescents he was becoming quite famous. Little did we -- or he -- know he would make history. For as it turned out, one evening around then he came home after work and, when his wife, Joan, asked how his research was going, replied "It's going very well. It just means, I think, the end of the world." It also earned him a Nobel Prize.

Professor F. Sherwood ("Sherry") Rowland died this week at 84.

The research he was referring to was his pioneering work showing that human use of aerosol compounds known as chlorofluorocarbons, or CFCs, present in spray cans and refrigerators of all kinds, was damaging to atmospheric ozone, which blocks the sun's ultraviolet rays -- and thus helped to allow life on earth to develop. His team's research had profound implications for the planet in a number of important ways, but most important, it showed we needed to do something sweeping and soon about an environmental threat.

Rowland's work, with his colleague and fellow 1995 chemistry Nobelist Mario Molina, thus also threatened some profits in the chemical industry. The scenario that unfolded was not unique -- attacks by the industry, both overt and stealth, and an unfortunate sort of shunning by some colleagues who did not want to be threatened by association. The aerosol industry even accused Rowland and Molina of "being K.G.B. agents out to destroy capitalism" -- McCarthyism lived (or rather, lives) on! Similar attacks on scientists predated Rowland -- such as the pioneering pesticide researcher and author Rachel Carson, and many who worked on showing the harms of tobacco. Rowland seems to have shrugged it off and continued his meticulous work. And of course, even before the Nobel, his colleagues came to recognize they had a true star in their midst.

Besides being a stellar scientist, Rowland was an eloquent writer, and in his Nobelist essay, he recalled his awakening to activism: "Mario and I realized that this was not just a scientific question, challenging and interesting to us, but a potentially grave environmental problem." His resultant advocacy for a ban on CFCs is a model of how good science can drive policy for the benefit of all. From their landmark 1974 paper on this topic -- "the initial reaction was absolutely nothing", he recalled -- to the 1987 international Montreal Protocol which stopped production and stockpiling of CFCs was only about 15 years -- a short span in such scenarios, where scientific and politicized controversy can delay real action for decades.

Rowland once reflected, with respect to his work and in the context of atmospheric and climate issues in general, "Is it enough for a scientist simply to publish a paper? Isn't it a responsibility of scientists, if you believe that you have found something that can affect the environment, isn't it your responsibility to actually do something about it, enough so that action actually takes place?... If not us, who? If not now, when?"

Dr. Molina this week told the New York Times that he and Dr. Rowland "were not sure we were going to be successful" in pushing for a ban on CFC's. "But we started something that was a very important precedent: people can make decisions and solve global problems."

Which, given the array of threats facing our species and planet -- climate change, overpopulation, chemical pollution, nuclear proliferation, the decline of science literacy and education, to name a few -- might be the most important lesson of our time. In the video interview below, Rowland said he was not optimistic about humans doing the right thing on climate change, but that he never gave up hope.

I have one fond memory of Rowland's sly humor. A few of the neighborhood teens were sitting in his kitchen; I had recently read about the dangers of pesticides on food and thought it would be good to ask a famous chemist about it (and maybe show off something I had read, too). "Are fruits and vegetables safe to eat now?" I asked. "Is there anything we can do to get pesticides off food?" Rowland looked at me with a shocked expression and said "You eat fruits and vegetables? What a novel idea!" -- and shot a scolding look at his son, sitting nearby. He then added, "Yes, wash them off the best you can. We're still trying to figure out how to keep them off the food in the first place."

Rowland was a scientific and environmental hero. But as the Times notes, he demurred from that label -- he just thought he was doing what he had to do, given what he'd learned. Everyone alive can thank him for that.

Read the original here:
Steve Heilig: Better Living Through Chemistry: A Reluctant Scientific and Environmental Hero Moves On

Ellman International Highlights New Scientific Presentations at the 2012 American Academy of Dermatology (AAD) Annual …

OCEANSIDE, N.Y., March 16, 2012 /PRNewswire/ --Ellman International is pleased to announce that it will showcase its Pelleve Wrinkle Reduction System, Ellumine Fractional CO2 Skin Resurfacing System and full line of Surgitron radiofrequency systems at the 70th Annual AAD Meeting in San Diego March 16 20, 2012.

Located at BOOTH #337, some of the country's top dermatologists will be on hand to give presentations about the benefits of the Pelleve System in a dermatologist's practice. Pelleve is a proven, effective, safe and virtually painless cosmetic treatment that reduces wrinkles on the face using advanced radiofrequency technology. Ellman will also be highlighting the Ellumine System, a fully flexible CO2 laser for a versatile range of treatments from full factional skin resurfacing to light touch ups, for a more gentle treatment and minimal downtime. The program covering these two industry-leading, anti-aging systems includes four days of strategic presentations.Ellman invites AAD attendees to learn about the solutions offered by Ellman through any of the presentations listed below:

Friday, March 16:

Saturday, March 17:

Sunday, March 18:

Monday, March 19:

Beyond Aesthetic TreatmentsAn innovative multi-modality system, the Pelleve Wrinkle Reduction System offers physicians unmatched versatility in a compact design. Physicians can use the Pelleve system to deliver aesthetic treatments as well as perform surgical treatments using the same S5 platform. The Pelleve S5 System incorporates the proven Surgitron technology, providing maximum control in precision cutting with minimal thermal damage to surrounding tissues, plus more versatility than other energy-based technologies, including:

Only the Pelleve Generator offers such unprecedented value and versatility of both non-invasive skin tightening and precise cutting and control for aesthetic surgical procedures.

Find updates and news on the AAD meeting on Twitter @AADMtgs.

About Ellman International

Continue reading here:
Ellman International Highlights New Scientific Presentations at the 2012 American Academy of Dermatology (AAD) Annual ...

Ellman International Highlights New Scientific Presentations at the 2012 American Academy of Dermatology (AAD) Annual …

OCEANSIDE, N.Y., March 16, 2012 /PRNewswire/ --Ellman International is pleased to announce that it will showcase its Pelleve Wrinkle Reduction System, Ellumine Fractional CO2 Skin Resurfacing System and full line of Surgitron radiofrequency systems at the 70th Annual AAD Meeting in San Diego March 16 20, 2012.

Located at BOOTH #337, some of the country's top dermatologists will be on hand to give presentations about the benefits of the Pelleve System in a dermatologist's practice. Pelleve is a proven, effective, safe and virtually painless cosmetic treatment that reduces wrinkles on the face using advanced radiofrequency technology. Ellman will also be highlighting the Ellumine System, a fully flexible CO2 laser for a versatile range of treatments from full factional skin resurfacing to light touch ups, for a more gentle treatment and minimal downtime. The program covering these two industry-leading, anti-aging systems includes four days of strategic presentations.Ellman invites AAD attendees to learn about the solutions offered by Ellman through any of the presentations listed below:

Friday, March 16:

Saturday, March 17:

Sunday, March 18:

Monday, March 19:

Beyond Aesthetic TreatmentsAn innovative multi-modality system, the Pelleve Wrinkle Reduction System offers physicians unmatched versatility in a compact design. Physicians can use the Pelleve system to deliver aesthetic treatments as well as perform surgical treatments using the same S5 platform. The Pelleve S5 System incorporates the proven Surgitron technology, providing maximum control in precision cutting with minimal thermal damage to surrounding tissues, plus more versatility than other energy-based technologies, including:

Only the Pelleve Generator offers such unprecedented value and versatility of both non-invasive skin tightening and precise cutting and control for aesthetic surgical procedures.

Find updates and news on the AAD meeting on Twitter @AADMtgs.

About Ellman International

Read more:
Ellman International Highlights New Scientific Presentations at the 2012 American Academy of Dermatology (AAD) Annual ...

Visiopharm’s New APPCenter Rapidly Expands Their APP Library and Introduces a Customer Contributor Program

Visiopharm
Visiopharm’s rapidly expands the APPCenter and showcases over 30 APPs for cancer research, diabetes, neuroscience, respiratory, and much more. APPs are created and validated in collaboration between experts in the field and Visiopharm application scientists and programmers. Experts benefit from the collaboration through Visiopharm’s new customer Contributor Program. The Contributor Program offers customers of the APPCenter the ability to earn discounts. A 30% or 50% discount is offered, depending on the type of Contributor a customer become.

Visiopharm’s rapidly expands their Application Protocol Package (APP) library to over 30 APPs, available now in their patent pending APPCenter. The APPCenter provide customers with easy access to an extensive library of ready-to-run APPs for cancer research, diabetes, neuroscience, respiratory, and much more. Each APP includes detailed descriptions, references to scientific literature, illustrated examples, webinars, and more. There is no need to become an expert in image analysis; APPs are created and validated in collaboration between experts in the field and Visiopharm’s application scientists and programmers. Some of the new APPs featured in the APPCenter include:

Ki67+MART1, Double-IHC for Melanoma of Skin:1 This APP automatically detects and quantifies Ki67 positive cells within tumor regions. No manual outlining of the tumor is needed, since the tumor region is automatically identified based on the Ki67/MART1-IHC double staining. The protocol provides the number of positive nuclei within the tumor region as well as the ratio compared to the total number of nuclei within the tumor region.

CD56, IHC, uNK cells within Endometrium for Recurrent Miscarriage:1 Immunohistochemical analysis of endometrial tissue sections has demonstrated increased density of CD56+ CD16- uNK cells in the mid-luteal phase endometrium in women suffering from idiopathic recurrent miscarriage and recurrent implantation failure compared to fertile controls.2 This APP is designed to work on approx. 3 ?m sections of endometrial tissue immunostained with anti-CD56 monoclonal antibody and counterstained with Mayer’s haematoxylin. The APP measures the ratio of uNK cells among the stromal cells near the epithelial edge. Cells in the glands and in the epithelial edge itself do not contribute to the calculations. HER2, SISH for Breast Cancer: 1 The APP is based on the Visiopharm HER2 SISH algorithm, which by automated image analysis determines the HER2 amplification in brightfield digital images of breast cancer tissue sections stained by the INFORMTM HER2 Dual ISH assay from Ventana/Roche. This assay includes the HER2 Silver ISH (SISH) probe resulting in discrete or clustered small black signals, and the centromer 17 Fast Red ISH probe resulting in discrete red signals. The overall ratio of black to red signals constitutes the HER2 gene amplification.

Customers try an APP free of charge, before investing, to make sure that 1) the APP is working according to specifications, 2) the APP provides useful results, and 3) the APP can be understood and operated.

Become a Visiopharm Expert and Earn Discounts

Visiopharm’s new Contributor Program offers customers of the APPCenter the ability to earn discounts. A 30% or 50% discount is offered, depending on the type of Contributor a customer become. Our Contributor levels include:

  • Reference Contributor: When an already available public APP is purchased from the APPCenter, a discount of 30% is given when the customer agrees to become a reference for the APP. Specifically, the customer’s name and institution can be listed as a user of the APP.

  • Co-author Contributor: When a Custom APP is developed, a discount of 50 % is given if the APP can be made public in the APPCenter after the custom development is complete. Co-author Contributors would support the APP being made public by providing example images, and the information necessary to create the description of the APP.

    Michael Grunkin PhD, CEO of Visiopharm, stated “Quantitative digital pathology often is a new discipline to life-science researchers; many do not have any previous experience and exposure to this discipline. Our Contributor Program provides a platform where researchers can share their expert knowledge within their respective research fields and earn significant discounts. Contributors will help demonstrate and support how to answer important research questions, in a transparent way, using quantitative digital pathology. The program creates a simple, risk-free way in which other researchers can follow in their footsteps. Our Contributor program was designed to become a valuable resource to the research community, and to encourage and reward the sharing of knowledge, experiences, and visions.”

    APPs are purchased for a low fixed cost, are yours to keep, and will work with both Visiopharm’s Deployed Analysis and their new Cloud Analysis solutions. Custom APPs can be developed upon request, at a fixed known cost, and are also risk free with a complimentary trial. For more information on how to join the Contributor Program please visit Visiopharm’s new website at http://www.visiopharm.com or contact Visiopharm’s Professional Services department at proservices@visiopharm.com.

    About Visiopharm

    Over the past 10 years, Visiopharm image analysis and stereology software has become the preferred Quantitative Digital Pathology solution for leading biopharmaceutical companies, clinical researchers, and academic researchers all over the world. Visiopharm has more than 300 deployed systems worldwide and a large network of distribution and support partners, and is featured in over 400 scientific publications.

    1 For research use only
    2 Endometrial cell counts in recurrent miscarriage: a comparison of counting methods, Josephine A Drury, Helena Nik, Robbert H F van Oppenraaij, Ai-Wei Tang, Mark A Turner & Siobhan Quenby, Histopathology 2011, 59, 1156-1162, 4/2 - 2011

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

An Entirely Automatic Method to Score Crypt Loss and Infiltration from Pathology Slides in a Mouse DSS Model of Colitis

This is a presentation by Cleopatra Kozlowski of Genentech at the Definiens Symposium in 2011 about using image analysis to score a mouse model of colitis. Much work has been done in the field of cancer biology and tumorigenesis but I think image analysis will prove increasingly important in non-neoplastic conditions such as inflammatory bowel disease (IBD) and neurodegenerative conditions. 

This video illustrates use of image analysis in IBD:

 

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

Eastday-Big stem cell breakthrough

A NEW stem cell therapy treatment to develop new bones for patients with bone loss and new skin for recipients of plastic surgery has been developed, doctors from Shanghai No.9 People's Hospital announced yesterday.

In the procedure, medical staff use a special machine to collect stem cells from a patient's blood. The stem cells adhere to a base made of a special biological material.

The stem cells are then transplanted into the patient's body, where they grow into either new bones or skin tissue, while the base is absorbed by the human body.

"So far the practice has been successful in treating patients with bone and skin loss," said Dr Dai Kerong from Shanghai Jiao Tong University's translational medicine institute at Shanghai No.9 hospital. "The stem cell technology will be used to develop corneas for blind people as well as treating heart attack and stroke patients by developing new heart and cerebral tissue."

The technology is patented in China and abroad and will be licensed within one or two years, according to Dai.

China has established 51 translational medicine centers to boost the introduction of laboratory research into clinical use.

The complicated procedures and documentation required often prevent doctors from introducing lab success into clinical practice.

Dai said one reagent developed by No. 9 hospital's doctors for in vitro fertilization received a license in Europe within six months and has been used in clinical practice "while this would take at least five years in China."

Excerpt from:
Eastday-Big stem cell breakthrough

Groundbreaking authors talk nutrition at O'Brien Family Farms in East Manatee

Authors to talk about

nutrition during visit to O'Brien Farms

EAST MANATEE -- O'Brien Family Farms, 16505 State Road 64 E., will host "Naked Calories" authors Mira Calton and Jayson Calton from 1 to 3 p.m. Saturday for a lecture and book signing.

The Caltons' story begins personally: By the time Mira Calton was 30 years old, she had the bone density of an 80-year-old woman. Her doctor's official diagnosis was advanced osteoporosis, and he prescribed a host of medications. But Mira preferred to take her health into her own hands and began a search for alternatives.

Moving to Florida to be closer to her family, she found Jayson Calton, a nutritional theorist with experience working with people who had chronic health conditions. He not only reversed her condition within two years, they bonded over their common passion and desire to help others uncover the sources of their disease through nutrition.

In 2005, they married and set off on a six-year, 100-country research journey to study the effects of modernization on the lifestyle and nutrition habits of people around the world. Their findings culminated in this book.

O'Brien Family Farms is a farm stand and educational center that features hydroponically grown fresh fruits and vegetables that customers can pick themselves or buy freshly picked.

-- Herald staff report

Read the original post:
Groundbreaking authors talk nutrition at O'Brien Family Farms in East Manatee